These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 14566839)
21. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610 [TBL] [Abstract][Full Text] [Related]
22. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. van Elsas A; van der Burg SH; van der Minne CE; Borghi M; Mourer JS; Melief CJ; Schrier PI Eur J Immunol; 1996 Aug; 26(8):1683-9. PubMed ID: 8765006 [TBL] [Abstract][Full Text] [Related]
23. Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TRAG-3 antigen. Zhu B; Chen Z; Cheng X; Lin Z; Guo J; Jia Z; Zou L; Wang Z; Hu Y; Wang D; Wu Y Clin Cancer Res; 2003 May; 9(5):1850-7. PubMed ID: 12738743 [TBL] [Abstract][Full Text] [Related]
24. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11. Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861 [TBL] [Abstract][Full Text] [Related]
25. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. Mohagheghpour N; Gammon D; Kawamura LM; van Vollenhoven A; Benike CJ; Engleman EG J Immunol; 1998 Sep; 161(5):2400-6. PubMed ID: 9725236 [TBL] [Abstract][Full Text] [Related]
26. Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. Skipper JC; Kittlesen DJ; Hendrickson RC; Deacon DD; Harthun NL; Wagner SN; Hunt DF; Engelhard VH; Slingluff CL J Immunol; 1996 Dec; 157(11):5027-33. PubMed ID: 8943411 [TBL] [Abstract][Full Text] [Related]
27. Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytes. Susskind B; Iannotti MR; Shornick MD; Steward NS; Gorka J; Mohanakumar T Hum Immunol; 1996 Mar; 46(1):1-9. PubMed ID: 9157083 [TBL] [Abstract][Full Text] [Related]
28. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041 [TBL] [Abstract][Full Text] [Related]
29. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells. Kawashima I; Tsai V; Southwood S; Takesako K; Sette A; Celis E Cancer Res; 1999 Jan; 59(2):431-5. PubMed ID: 9927058 [TBL] [Abstract][Full Text] [Related]
30. A HLA-A2 restricted human CTL line recognizes a novel tumor cell expressed p53 epitope. Würtzen PA; Claesson MH Int J Cancer; 2002 Jun; 99(4):568-72. PubMed ID: 11992547 [TBL] [Abstract][Full Text] [Related]
31. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53. Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253 [TBL] [Abstract][Full Text] [Related]
32. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements. Huarte E; Sarobe P; Lu J; Casares N; Lasarte JJ; Dotor J; Ruiz M; Prieto J; Celis E; Borrás-Cuesta F Clin Cancer Res; 2002 Jul; 8(7):2336-44. PubMed ID: 12114438 [TBL] [Abstract][Full Text] [Related]
33. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1. Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343 [TBL] [Abstract][Full Text] [Related]
34. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis. Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095 [TBL] [Abstract][Full Text] [Related]
35. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes. Lu J; Celis E Cancer Res; 2000 Sep; 60(18):5223-7. PubMed ID: 11016651 [TBL] [Abstract][Full Text] [Related]
36. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice. Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226 [TBL] [Abstract][Full Text] [Related]
37. [In vitro induction of immune response by dendritic cells pulsed with TRAG-3-derived cytotoxic T lymphocyte epitope]. Zhu B; Chen ZT; Cheng XM; Wu YZ Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):709-12. PubMed ID: 15733385 [TBL] [Abstract][Full Text] [Related]
38. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody]. Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545 [TBL] [Abstract][Full Text] [Related]
39. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck. Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724 [TBL] [Abstract][Full Text] [Related]
40. Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s). Imro MA; Manici S; Russo V; Consogno G; Bellone M; Rugarli C; Traversari C; Protti MP Cancer Res; 1999 May; 59(10):2287-91. PubMed ID: 10344730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]